Jacobs Levy Equity Management, Inc Emergent Bio Solutions Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 185,317 shares of EBS stock, worth $1.72 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
185,317Holding current value
$1.72 Million% of portfolio
0.01%Shares
16 transactions
Others Institutions Holding EBS
# of Institutions
158Shares Held
32.9MCall Options Held
424KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$35.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$31.5 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$23.1 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$20.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$17.7 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $462M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...